AdaptHealth (AHCO) Cost of Revenue (2019 - 2026)

AdaptHealth's Cost of Revenue history runs 8 years deep, the most recent figure standing at $708.3 million for Q1 2026.

• In Q1 2026, Cost of Revenue rose 7.74% year-over-year to $708.3 million; the TTM figure through Mar 2026 stood at $2.7 billion (up 3.24% YoY), while the FY2025 annual figure was $2.6 billion, up 2.16% from the prior year.
• Cost of Revenue was $708.3 million for Q1 2026 at AdaptHealth, up from $674.1 million in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $708.3 million in Q1 2026 to a low of $536.6 million in Q4 2022.
• Historically, Cost of Revenue has averaged $640.6 million across 5 years, with a median of $646.7 million in 2022.
• Biggest YoY gain for Cost of Revenue was 50.52% in 2022; the steepest drop was 9.29% in 2022.
• A 5-year view of Cost of Revenue shows it stood at $536.6 million in 2022, then increased by 3.2% to $553.8 million in 2023, then climbed by 19.97% to $664.4 million in 2024, then grew by 1.46% to $674.1 million in 2025, then increased by 5.07% to $708.3 million in 2026.
• The last three Cost of Revenue figures came in at $708.3 million (Q1 2026), $674.1 million (Q4 2025), and $658.4 million (Q3 2025), per Business Quant data.